Last 12 months
Inside the activity.
12 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 10 | 0 |
| Mar 2026 | 2 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2022 Filed Jun 17, 2022 20:22 UTC |
SHERMAN STEVENDirector · CEO & Chairman
|
SaleCommon Stock | 6,911 | $1.90 | $13,118.46 |
DisclosureSEC source: 0001549084-22-000035 · wf-form4_165551172719268.xml · nonDerivative · entry 2 SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 648,762 F3 · shares: Represents shares sold by the Reporting Person on June 15, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the Reporting Person's RSUs. F4 · price: The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $1.88 to $1.94, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request. Read SEC document |
| June 09, 2022 Filed Jun 18, 2022 00:36 UTC |
Cloyd Mary AnnDirector
|
GrantCommon Stock | 51,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001666769-22-000004 · wf-form4_165551258388396.xml · nonDerivative · entry 2 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,896 F1 · security: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting. F3 · date: This award of RSUs was granted effective June 9, 2022, the date of the Company's 2022 annual meeting of stockholders (the "Second Grant Date"), pursuant to the Annual RSU Grant Program. The RSUs are scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the Second Grant Date. Read SEC document |
| June 09, 2022 Filed Jun 17, 2022 20:30 UTC |
Stern StanleyDirector
|
GrantCommon Stock | 51,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001316499-22-000004 · wf-form4_165551219037780.xml · nonDerivative · entry 2 Stern Stanley · CIK 0001316499 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,221 F1 · security: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting. F3 · date: This award of RSUs was granted effective June 9, 2022, the date of the Company's 2022 annual meeting of stockholders (the "Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021. The RSUs are scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the Grant Date. Read SEC document |
| June 09, 2022 Filed Jun 18, 2022 00:34 UTC |
Li KechengDirector
|
GrantCommon Stock | 51,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001735083-22-000004 · wf-form4_165551243039722.xml · nonDerivative · entry 2 Li Kecheng · CIK 0001735083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,129 F1 · security: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting. F3 · date: This award of RSUs was granted effective June 9, 2022, the date of the Company's 2022 annual meeting of stockholders (the "Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021. The RSUs are scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the Grant Date. Read SEC document |
| June 09, 2022 Filed Jun 18, 2022 00:18 UTC |
Wallen Rhonda A.Director
|
GrantCommon Stock | 51,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001838009-22-000003 · wf-form4_165551150324187.xml · nonDerivative · entry 2 Wallen Rhonda A. · CIK 0001838009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,896 F1 · security: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting. F3 · date: This award of RSUs was granted effective June 9, 2022, the date of the Company's 2022 annual meeting of stockholders (the "Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021. The RSUs are scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the Grant Date. Read SEC document |
| June 09, 2022 Filed Jul 18, 2022 22:37 UTC |
Lathan CorinnaDirector
|
GrantCommon Stock | 51,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001714701-22-000004 · wf-form4_165818386173286.xml · nonDerivative · entry 1 Lathan Corinna · CIK 0001714701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,865 F1 · security: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting. F2 · date: This award of RSUs was granted effective June 9, 2022, the date of the Company's 2022 annual meeting of stockholders (the "Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021. The RSUs are scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the Grant Date. Read SEC document |
| May 25, 2022 Filed May 26, 2022 20:33 UTC |
Davis Scott G.President & COO
|
GrantCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-032210 · doc4.xml · nonDerivative · entry 1 Davis Scott G. · CIK 0001908860 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 373,815 F1 · security: Represents restricted stock units ("RSUs"). F2 · date: The RSU grant was approved by the Compensation Committee of the Board of Directors on May 25, 2022. F3 · shares: 1/3 of the total number of shares of Common Stock subject to the RSUs will vest on January 21st of each year beginning in 2023. Read SEC document |
| May 24, 2022 Filed May 26, 2022 20:32 UTC |
SHERMAN STEVENDirector · CEO & Chairman
|
SaleCommon Stock | 6,597 | $1.76 | $11,604.78 |
DisclosureSEC source: 0001549084-22-000027 · wf-form4_165361154083193.xml · nonDerivative · entry 1 SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 637,408 F1 · shares: Represents shares sold by the Reporting Person on May 24, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the fourth installment of a restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on March 10, 2022 F2 · price: The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $1.75 to $1.77, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request. Read SEC document |
| May 21, 2022 Filed May 24, 2022 19:07 UTC |
SHERMAN STEVENDirector · CEO & Chairman
|
Exercise / conversionRestricted Stock Units · Derivative | 15,599 | $0.00 | $0.00 |
DisclosureSEC source: 0001549084-22-000025 · wf-form4_165343361267752.xml · derivative · entry 2 SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,794 Underlying: Common Stock · 15,599 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units ("RSUs") were granted on March 8, 2022 in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date"). F2 · derivative.exercise_date: The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested as of January 21, 2023. The fourth installment of RSUs vested on May 21, 2022 and were delivered to the Reporting Person upon settlement. F2 · derivative.expiration_date: The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested as of January 21, 2023. The fourth installment of RSUs vested on May 21, 2022 and were delivered to the Reporting Person upon settlement. Read SEC document |
| May 21, 2022 Filed May 24, 2022 19:07 UTC |
SHERMAN STEVENDirector · CEO & Chairman
|
Exercise / conversionCommon Stock | 15,599 | $0.00 | $0.00 |
DisclosureSEC source: 0001549084-22-000025 · wf-form4_165343361267752.xml · nonDerivative · entry 1 SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 644,005 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2022 Filed May 2, 2022 17:28 UTC |
SHERMAN STEVENDirector · CEO & Chairman
|
SaleCommon Stock | 6,862 | $2.41 | $16,520.95 |
DisclosureSEC source: 0001209191-22-026448 · doc4.xml · nonDerivative · entry 1 SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 628,406 F1 · shares: Represents shares sold by the Reporting Person on April 28, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the third installment of a restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on March 10, 2022. F2 · price: The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $2.38 to $2.43, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request. Read SEC document |
| April 21, 2022 Filed Apr 25, 2022 16:47 UTC |
SHERMAN STEVENDirector · CEO & Chairman
|
Exercise / conversionRestricted Stock Units · Derivative | 15,599 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025531 · doc4.xml · derivative · entry 2 SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,393 Underlying: Common Stock · 15,599 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units ("RSUs") were granted on March 8, 2022 in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date"). F2 · derivative.exercise_date: The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested as of January 21, 2023. The third installment of RSUs vested on April 21, 2022 and were delivered to the Reporting Person upon settlement. F2 · derivative.expiration_date: The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested as of January 21, 2023. The third installment of RSUs vested on April 21, 2022 and were delivered to the Reporting Person upon settlement. Read SEC document |
| April 21, 2022 Filed Apr 25, 2022 16:47 UTC |
SHERMAN STEVENDirector · CEO & Chairman
|
Exercise / conversionCommon Stock | 15,599 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025531 · doc4.xml · nonDerivative · entry 1 SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 635,268 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 20, 2022 Filed Apr 26, 2022 21:13 UTC |
Davis Scott G.President & COO
|
SaleCommon Stock | 4,043 | $2.62 | $10,582.96 |
DisclosureSEC source: 0001209191-22-025648 · doc4.xml · nonDerivative · entry 1 Davis Scott G. · CIK 0001908860 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,815 F1 · shares: Represents shares sold by the Reporting Person on April 20, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the first installment of restricted stock awards originally reported by the Reporting Person in a Form 4 filed with the Commission on February 22, 2022. F2 · price: The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $2.61 to $2.63, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request. Read SEC document |
| April 07, 2022 Filed Apr 11, 2022 18:10 UTC |
Jones Jason CVP of Product Development
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-024037 · doc4.xml · nonDerivative · entry 1 Jones Jason C · CIK 0001775619 · VP of Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,637 F1 · security: Represents restricted stock units ("RSUs"). F2 · date: The grant of RSUs was approved by the Compensation Committee of the Board of Directors on April 7, 2022. F3 · shares: 1/3 of the total number of shares of Common Stock subject to the RSUs shall vest on August 30th of each year beginning 2022. Read SEC document |
| March 24, 2022 Filed Mar 25, 2022 20:53 UTC |
SHERMAN STEVENDirector · CEO & Chairman
|
SaleCommon Stock | 6,389 | $2.94 | $18,783.66 |
DisclosureSEC source: 0001209191-22-021200 · doc4.xml · nonDerivative · entry 1 SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 619,669 F1 · shares: Represents shares sold by the Reporting Person on March 24, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the second installment of a restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on March 10, 2022. F2 · price: The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $2.91 to $2.9767, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request. Read SEC document |
| March 22, 2022 Filed Mar 28, 2022 16:44 UTC |
Jones Jason CVP of Product Development
|
SaleCommon Stock | 3,265 | $2.82 | $9,206.32 |
DisclosureSEC source: 0001209191-22-021328 · doc4.xml · nonDerivative · entry 1 Jones Jason C · CIK 0001775619 · VP of Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,637 F1 · shares: Represents shares sold by the Reporting Person on March 22, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the first installment of restricted stock awards reported by the Reporting Person in Form 4s filed with the Commission on February 22, 2022 and March 5, 2021. F2 · price: The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $2.88 to $2.81, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request. Read SEC document |
| March 22, 2022 Filed Mar 28, 2022 20:52 UTC |
GLENN JOHNChief Financial Officer
|
SaleCommon Stock | 3,462 | $2.82 | $9,761.80 |
DisclosureSEC source: 0001209191-22-021330 · doc4.xml · nonDerivative · entry 1 GLENN JOHN · CIK 0001253497 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,130 F1 · shares: Represents shares sold by the Reporting Person on March 22, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the first installment of restricted stock awards reported by the Reporting Person in Form 4s filed with the Commission on February 22, 2022 and March 5, 2021. F2 · price: The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $2.88 to $2.81, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request. Read SEC document |
| March 21, 2022 Filed Mar 22, 2022 16:55 UTC |
SHERMAN STEVENDirector · CEO & Chairman
|
Exercise / conversionRestricted Stock Units · Derivative | 15,599 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-020558 · doc4.xml · derivative · entry 2 SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,992 Underlying: Common Stock · 15,599 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units ("RSUs") were granted on March 8, 2022 in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date"). F2 · derivative.exercise_date: The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested and settled as of January 21, 2023. The second installment of RSUs vested and were delivered to the Reporting Person on March 21, 2022. F2 · derivative.expiration_date: The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested and settled as of January 21, 2023. The second installment of RSUs vested and were delivered to the Reporting Person on March 21, 2022. Read SEC document |
| March 21, 2022 Filed Mar 22, 2022 16:55 UTC |
SHERMAN STEVENDirector · CEO & Chairman
|
Exercise / conversionCommon Stock | 15,599 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-020558 · doc4.xml · nonDerivative · entry 1 SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 626,058 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 17:19 UTC |
SHERMAN STEVENDirector · CEO & Chairman
|
SaleCommon Stock | 5,965 | $2.60 | $15,508.40 |
DisclosureSEC source: 0001209191-22-019690 · doc4.xml · nonDerivative · entry 1 SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 610,459 F1 · shares: Represents shares sold by the Reporting Person on March 15, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the first installment of a restricted stock unit award originally reported by the Reporting Person in Form 4 filed with the Commission on March 10, 2022. F2 · price: The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $2.5980 to $2.60, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 17:07 UTC |
SHERMAN STEVENDirector · CEO & Chairman
|
Exercise / conversionRestricted Stock · Derivative | 15,599 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-017980 · doc4.xml · derivative · entry 3 SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,591 Underlying: Common Stock · 15,599 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares represent restricted stock units ("RSUs") granted in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date"). The Issuer's Compensation Committee formally authorized the grant of such RSUs and the related RSU Agreement on March 8, 2022. F3 · derivative.exercise_date: The first installment of the RSUs vested on February 21, 2022 and were delivered to the Reporting Person immediately in connection with the execution of the RSU Agreement. F3 · derivative.expiration_date: The first installment of the RSUs vested on February 21, 2022 and were delivered to the Reporting Person immediately in connection with the execution of the RSU Agreement. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 17:07 UTC |
SHERMAN STEVENDirector · CEO & Chairman
|
GrantRestricted Stock Units · Derivative | 187,190 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-017980 · doc4.xml · derivative · entry 2 SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,190 Underlying: Common Stock · 187,190 shares Expires not disclosed F1 · derivative.exercise_price: Shares represent restricted stock units ("RSUs") granted in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date"). The Issuer's Compensation Committee formally authorized the grant of such RSUs and the related RSU Agreement on March 8, 2022. F2 · derivative.exercise_date: The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested on January 21, 2023. F2 · derivative.expiration_date: The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested on January 21, 2023. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 17:07 UTC |
SHERMAN STEVENDirector · CEO & Chairman
|
Exercise / conversionCommon Stock | 15,599 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-017980 · doc4.xml · nonDerivative · entry 1 SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 616,424 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2022 Filed May 17, 2023 19:46 UTC Amendment |
SHERMAN STEVENExecutive Chair
|
Exercise / conversionRestricted Stock Units · Derivative | 15,599 | $0.00 | $0.00 |
DisclosureSEC source: 0001549084-23-000033 · wk-form4a_1684367209.xml · derivative · entry 2 SHERMAN STEVEN · CIK 0001201619 · Executive Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,591 Underlying: Common Stock · 15,599 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Shares represent restricted stock units ("RSUs") granted in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date"). The Issuer's Compensation Committee formally authorized the grant of such RSUs and the related RSU Agreement on March 8, 2022. F3 · derivative.exercise_date: The first installment of the RSUs vested on February 21, 2022 and were delivered to the Reporting Person immediately in connection with the execution of the RSU Agreement. F3 · derivative.expiration_date: The first installment of the RSUs vested on February 21, 2022 and were delivered to the Reporting Person immediately in connection with the execution of the RSU Agreement. Read SEC document |
| March 08, 2022 Filed May 17, 2023 19:46 UTC Amendment |
SHERMAN STEVENExecutive Chair
|
Exercise / conversionCommon Stock | 15,599 | $0.00 | $0.00 |
DisclosureSEC source: 0001549084-23-000033 · wk-form4a_1684367209.xml · nonDerivative · entry 1 SHERMAN STEVEN · CIK 0001201619 · Executive Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: On March 10, 2022, the Reporting Person filed a Form 4 that did not reflect the decrease in the Reporting Person's holdings caused by the Issuer's 1-for-15 reverse stock split effected on March 24, 2020. This Amendment corrects such inaccuracies. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 19:27 UTC |
Jones Jason CVP of Product Development
|
GrantCommon Stock | 13,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-011955 · doc4.xml · nonDerivative · entry 1 Jones Jason C · CIK 0001775619 · VP of Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,902 F1 · shares: Shares acquired pursuant to a restricted stock units award granted on March 3, 2021 that had both performance-based and time-based vesting conditions. The performance-based vesting conditions have been satisfied, and now the award is subject only to time-based vesting conditions. The award vests in three equal annual installments beginning on March 3, 2022. Read SEC document |
| February 17, 2022 Filed Feb 23, 2022 00:23 UTC |
GLENN JOHNChief Financial Officer
|
GrantCommon Stock | 14,596 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-011950 · doc4.xml · nonDerivative · entry 1 GLENN JOHN · CIK 0001253497 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,592 F1 · shares: Shares acquired pursuant to a restricted stock units award granted on March 3, 2021 that had both performance-based and time-based vesting conditions. The performance-based vesting conditions have been satisfied, and now the award is subject only to time-based vesting conditions. The award vests in three equal annual installments beginning on March 3, 2022. Read SEC document |
| February 17, 2022 Filed Feb 23, 2022 00:36 UTC |
Davis Scott G.President & COO
|
GrantCommon Stock | 41,158 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-011959 · doc4.xml · nonDerivative · entry 1 Davis Scott G. · CIK 0001908860 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,858 F1 · shares: Shares acquired pursuant to a restricted stock units award granted on April 8, 2021 that had both performance-based and time-based vesting conditions. The performance-based vesting conditions have been satisfied, and now the award is subject only to time-based vesting conditions. The award vests in three equal annual installments beginning on April 8, 2022. Read SEC document |
| February 17, 2022 Filed Feb 23, 2022 00:33 UTC |
Shaw William RChief Commercial Officer
|
GrantCommon Stock | 17,943 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-011958 · doc4.xml · nonDerivative · entry 1 Shaw William R · CIK 0001776374 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,943 F1 · shares: Shares acquired pursuant to a restricted stock units award granted on March 3, 2021 that had both performance-based and time-based vesting conditions. The performance-based vesting conditions have been satisfied, and now the award is subject only to time-based vesting conditions. The award vests in three equal annual installments beginning on March 3, 2022. Read SEC document |
| February 17, 2022 Filed Jun 15, 2023 21:59 UTC |
Jones Jason CChief Operating Officer
|
GrantCommon Stock | 3,346 | $0.00 | $0.00 |
DisclosureSEC source: 0001549084-23-000045 · wk-form4_1686880789.xml · nonDerivative · entry 4 Jones Jason C · CIK 0001775619 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By 401K Disclosed balance after: 4,491 Read SEC document |
| February 17, 2022 Filed Apr 4, 2024 21:21 UTC Amendment |
Jones Jason CChief Operating Officer
|
GrantCommon Stock | 3,446 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-011125 · rdgdoc.xml · nonDerivative · entry 1 Jones Jason C · CIK 0001775619 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By 401(k) Disclosed balance after: 4,591 F1 · shares: On June 15, 2023, the Reporting Person filed a Form 4 that stated the incorrect number of shares of common stock acquired in connection with the Issuer's 401(k) plan matching contribution which occurred on 2/17/2022. This amendment corrects such inaccuracy and the related total number of securities indirectly owned at that date and subsequently. F1 · balance_after: On June 15, 2023, the Reporting Person filed a Form 4 that stated the incorrect number of shares of common stock acquired in connection with the Issuer's 401(k) plan matching contribution which occurred on 2/17/2022. This amendment corrects such inaccuracy and the related total number of securities indirectly owned at that date and subsequently. Read SEC document |
| December 25, 2021 Filed Dec 28, 2021 22:21 UTC |
Lathan CorinnaDirector
|
GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013595 · form4.xml · nonDerivative · entry 1 Lathan Corinna · CIK 0001714701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,144 F1 · price: The grant consists of Restricted Stock Units that will fully vest and settle at the earlier of (i) the date of the next annual meeting of stockholders or (ii) December 25, 2022. F2 · balance_after: This includes 144 shares directly held in joint ownership with reporting person's spouse. Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 20:29 UTC |
Peurach JackDirector · President & CEO
|
GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-054442 · doc4.xml · nonDerivative · entry 1 Peurach Jack · CIK 0001640206 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,142 F1 · security: Represents restricted stock units ("RTUs"). F2 · date: The grant of RSUs was approved by the compensation committee of the board of directors on August 31, 2021. F3 · shares: 1/3 of the total number of shares of Common Stock subject to the RSUs shall vest on August 31st of each year beginning 2022. Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 20:41 UTC |
Jones Jason CVP of Product Development
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-049812 · doc4.xml · nonDerivative · entry 1 Jones Jason C · CIK 0001775619 · VP of Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,142 F1 · security: Represents restricted stock units ("RSUs"). F2 · date: The grant of RSUs was approved by the compensation committee of the board of directors on August 1, 2021. F3 · shares: 1/3 of the total number of shares of Common Stock subject to the RSUs shall vest on August 30th of each year beginning 2022. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 00:38 UTC |
Shaw William RChief Commercial Officer
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-049811 · doc4.xml · nonDerivative · entry 1 Shaw William R · CIK 0001776374 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,000 F1 · security: Represents restricted stock units ("RSUs"). F2 · date: The grant of RSUs was approved by the compensation committee of the board of directors on August 1, 2021. F3 · shares: 1/3 of the total number of shares of Common Stock subject to the RSUs shall vest on August 30th of each year beginning 2022. Read SEC document |
| June 10, 2021 Filed Jun 18, 2022 00:36 UTC |
Cloyd Mary AnnDirector
|
GrantCommon Stock | 18,265 | $0.00 | $0.00 |
DisclosureSEC source: 0001666769-22-000004 · wf-form4_165551258388396.xml · nonDerivative · entry 1 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,175 F1 · security: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting. F2 · date: This award of RSUs was granted effective June 10, 2021, the date of the Company's 2021 annual meeting of stockholders (the "First Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021 (the "Annual RSU Grant Program"). The RSUs were scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the First Grant Date, and accordingly fully vested on June 9, 2022, the date of the Company's 2022 annual meeting of stockholders. Read SEC document |
| June 10, 2021 Filed Jun 17, 2022 20:30 UTC |
Stern StanleyDirector
|
GrantCommon Stock | 18,265 | $0.00 | $0.00 |
DisclosureSEC source: 0001316499-22-000004 · wf-form4_165551219037780.xml · nonDerivative · entry 1 Stern Stanley · CIK 0001316499 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,500 F1 · security: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting. F2 · date: This award of RSUs was granted effective June 10, 2021, the date of the Company's 2021 annual meeting of stockholders (the "First Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021 (the "Annual RSU Grant Program"). The RSUs were scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the First Grant Date, and accordingly fully vested on June 9, 2022, the date of the Company's 2022 annual meeting of stockholders. Read SEC document |
| June 10, 2021 Filed Jun 17, 2022 20:22 UTC |
SHERMAN STEVENDirector · CEO & Chairman
|
GrantCommon Stock | 18,265 | $0.00 | $0.00 |
DisclosureSEC source: 0001549084-22-000035 · wf-form4_165551172719268.xml · nonDerivative · entry 1 SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 655,673 F1 · security: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting. F2 · date: This award of RSUs was granted effective June 10, 2021, the date of the Company's 2021 annual meeting of stockholders (the "First Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021 (the "Annual RSU Grant Program"). The RSUs were scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the First Grant Date, and accordingly fully vested on June 9, 2022, the date of the Company's 2022 annual meeting of stockholders. Read SEC document |
| June 10, 2021 Filed Jun 18, 2022 00:34 UTC |
Li KechengDirector
|
GrantCommon Stock | 18,265 | $0.00 | $0.00 |
DisclosureSEC source: 0001735083-22-000004 · wf-form4_165551243039722.xml · nonDerivative · entry 1 Li Kecheng · CIK 0001735083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,408 F1 · security: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting. F2 · date: This award of RSUs was granted effective June 10, 2021, the date of the Company's 2021 annual meeting of stockholders (the "First Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021 (the "Annual RSU Grant Program"). The RSUs were scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the First Grant Date, and accordingly fully vested on June 9, 2022, the date of the Company's 2022 annual meeting of stockholders. Read SEC document |
| June 10, 2021 Filed Jun 18, 2022 00:18 UTC |
Wallen Rhonda A.Director
|
GrantCommon Stock | 18,265 | $0.00 | $0.00 |
DisclosureSEC source: 0001838009-22-000003 · wf-form4_165551150324187.xml · nonDerivative · entry 1 Wallen Rhonda A. · CIK 0001838009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,175 F1 · security: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting. F2 · date: This award of RSUs was granted effective June 10, 2021, the date of the Company's 2021 annual meeting of stockholders (the "First Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021 (the "Annual RSU Grant Program"). The RSUs were scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the First Grant Date, and accordingly fully vested on June 9, 2022, the date of the Company's 2022 annual meeting of stockholders. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 16:53 UTC |
Jones Jason CVP of Product Development
|
GrantCommon Stock | 12,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-018271 · doc4.xml · nonDerivative · entry 1 Jones Jason C · CIK 0001775619 · VP of Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,142 F1 · security: Represents restricted stock units ("RSUs"). F2 · date: The grant of RSUs was approved by the compensation committee of the board of directors on March 3, 2021. F3 · shares: The grant consists of RSUs that vest annually over three years. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 21:41 UTC |
GLENN JOHNChief Financial Officer
|
GrantCommon Stock | 13,015 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-018246 · doc4.xml · nonDerivative · entry 1 GLENN JOHN · CIK 0001253497 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,996 F1 · security: Represents restricted stock units ("RSUs"). F2 · date: The grant of RSUs was approved by the compensation committee of the board of directors on March 3, 2021. F3 · shares: The grant consists of RSUs that vest annually over three years. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 21:49 UTC |
Shaw William RChief Commercial Officer
|
GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-018264 · doc4.xml · nonDerivative · entry 1 Shaw William R · CIK 0001776374 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,000 F1 · security: Represents restricted stock units ("RSUs"). F2 · date: The grant of RSUs was approved by the compensation committee of the board of directors on March 3, 2021. F3 · shares: The grant consists of RSUs that vest annually over three years. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 21:37 UTC |
Peurach JackDirector · Chief Executive Officer
|
GrantCommon Stock | 45,725 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-018237 · doc4.xml · nonDerivative · entry 1 Peurach Jack · CIK 0001640206 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,267 F1 · security: Represents restricted stock units ("RSUs"). F2 · date: The grant of RSUs was approved by the compensation committee of the board of directors on March 3, 2021. F3 · shares: The grant consists of RSUs that vest annually over three years. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 21:36 UTC |
Cloyd Mary AnnDirector
|
GrantCommon Stock | 4,910 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-012717 · doc4.xml · nonDerivative · entry 1 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,910 F1 · price: The grant consists of RSUs that fully vest on December 29, 2021. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 21:35 UTC |
Wallen Rhonda A.Director
|
GrantCommon Stock | 4,910 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-012715 · doc4.xml · nonDerivative · entry 1 Wallen Rhonda A. · CIK 0001838009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,910 F1 · price: The grant consists of RSUs that fully vest on December 29, 2021. Read SEC document |
| January 28, 2021 Filed Jun 15, 2023 21:59 UTC |
Jones Jason CChief Operating Officer
|
GrantCommon Stock | 1,145 | $0.00 | $0.00 |
DisclosureSEC source: 0001549084-23-000045 · wk-form4_1686880789.xml · nonDerivative · entry 3 Jones Jason C · CIK 0001775619 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By 401K Disclosed balance after: 1,145 Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 16:07 UTC |
Wang Theodore TDirector
|
OtherCommon Stock | 744,572 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-057907 · doc4.xml · nonDerivative · entry 1 Wang Theodore T · CIK 0001694061 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Puissance Cross-Border Opportunities II LLC Disclosed balance after: 29,828 F1 · kind: Puissance Cross-Border Opportunities II LLC made an in-kind distribution of an aggregate 744,572 shares of the Issuer's common stock to one of its limited partners in connection with the redemption of partnership interests. F1 · price: Puissance Cross-Border Opportunities II LLC made an in-kind distribution of an aggregate 744,572 shares of the Issuer's common stock to one of its limited partners in connection with the redemption of partnership interests. F2 · ownership.direct: These securities are held directly by Puissance Cross-Border Opportunities II LLC and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Cross Border Opportunities II LLC; Puissance Capital Management (GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Cross Border Opportunities II LLC; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| July 23, 2020 Filed Jul 27, 2020 16:29 UTC |
SCHRECK THOMAS ADirector
|
GrantCommon Stock | 7,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-043727 · doc4.xml · nonDerivative · entry 1 SCHRECK THOMAS A · CIK 0001134622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,698 F1 · price: The grant consists of RSUs that fully vest one year from the date of grant, or July 23, 2021. F2 · balance_after: After taking into account the 1-for-15 reverse stock split effective March 24, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.